2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
CNS
1
Conditions
Multiple Myeloma
121
Neoplasms, Plasma Cell
36
Neoplasms
14
Carcinoma, Hepatocellular
13
Recurrence
12
Brain Neoplasms
12
Prostatic Neoplasms
11
Melanoma
11
Central Nervous System Neoplasms
11
Glioblastoma
10
Leukemia
9
Carcinoma, Non-Small-Cell Lung
9
Leukemia, Lymphocytic, Chronic, B-Cell
8
Gliosarcoma
8
Waldenstrom Macroglobulinemia
7
Sarcoma
7
Lung Neoplasms
7
Glioma
7
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Liver Neoplasms
6
Myeloproliferative Disorders
5
Myelodysplastic Syndromes
5
Lymphoma, Mantle-Cell
5
Lymphoma, B-Cell, Marginal Zone
5
Lymphoma
5
Kidney Neoplasms
5
Immunoglobulin Light-chain Amyloidosis
5
Myelodysplastic-Myeloproliferative Diseases
4
Lymphoma, Follicular
4
Interventions
Carboplatin
26
Etoposide
22
Vincristine
18
Melphalan
14
Filgrastim
14
Topotecan
11
Granulocyte Colony-Stimulating Factor
10
Cyclophosphamide
9
Thiotepa
7
Cryotherapy
7
Peripheral Blood Stem Cell Transplantation
4
Mesna
4
Drug Therapy
4
Busulfan
4
Radiotherapy
3
Ifosfamide
3
Doxorubicin
3
Brachytherapy
3
Watchful Waiting
2
Temozolomide
2
Platinum Compounds
2
Magnetic Resonance Imaging
2
Eye Enucleation
2
Cisplatin
2
Blood Specimen Collection
2
trioctyl phosphine oxide
1
sargramostim
1
racotumomab
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Retinoblastoma
×
Thalidomide
×
Clear all
NCT01661400
2024-01-31
ASCR
Washington University School of Medicine
Phase 1
Completed
14 enrolled